G. Pelton

R. V. Van Heertum, J. Mann, Y. Stern, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease

J. Mann, R. Parsey, H. Rusinek, 2009, Alzheimer's & Dementia.

Utility of Molecular and Structural Brain Imaging to Predict Progression from MCI to Dementia

R. Parsey, D. Devanand, G. Pradhaban, 2017 .

A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer's Disease

Y. Stern, D. Devanand, G. Pelton, 2012, Alzheimer's & Dementia.

Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder

J. Petrella, P. Doraiswamy, D. Devanand, 2018, International journal of geriatric psychiatry.

Limited efficacy of ketoconazole in treatment-refractory major depression.

C. McDougle, A. Anand, G. Pelton, 1999, Journal of clinical psychopharmacology.

Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.

K. Marder, D. Devanand, G. Pelton, 2017, Alzheimer disease and associated disorders.

An open treatment trial of duloxetine in elderly patients with dysthymic disorder

G. Pelton, S. Roose, J. Ferrar, 2014, SAGE open medicine.

A randomized, prospective pilot study of patient expectancy and antidepressant outcome

G. Pelton, S. Marcus, S. Roose, 2012, Psychological Medicine.

Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

C. McDougle, A. Anand, W. Goodman, 1995, The American journal of psychiatry.

Antiglucocorticoids as Treatments for Depression

C. McDougle, G. Pelton, L. Price, 1996, CNS drugs.

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography

Linda Carpenter, John P Seibyl, Robert B Innis, 1998, Biological Psychiatry.

Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.

H. Sackeim, D. Devanand, G. Pelton, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults.

D. Devanand, G. Pradhaban, G. Pelton, 2018, Journal of Alzheimer's disease : JAD.

Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex

Younglim Lee, Michael Davis, G. Pelton, 1997, Brain Research.

Antiglucocorticoid Medication for the Treatment of Depression: Theory and Current Practice

G. Pelton, 2000 .

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial

Y. Stern, D. Devanand, G. Pelton, 2020, BMJ Open.

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.

H. Sackeim, K. Marder, R. Mayeux, 1998, The American journal of psychiatry.

Treatment of clozapine-induced parotid gland swelling.

G. Pelton, L. Price, E. Brodkin, 1996, The American journal of psychiatry.

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.

C. McDougle, G. Pelton, L. Price, 2000, Archives of general psychiatry.

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

C. McDougle, G. Pelton, D. Cohen, 1998, Archives of general psychiatry.

Effect of varied training techniques on field endotracheal intubation success rates.

P. Paris, G. Pelton, R. Stewart, 1984, Annals of emergency medicine.

Field endotracheal intubation by paramedical personnel. Success rates and complications.

P. Paris, G. Pelton, P. Winter, 1984, Chest.

Arterial blood gases before, during, and after nitrous oxide:oxygen administration.

G. Pelton, R. Stewart, M. Gorayeb, 1986, Annals of emergency medicine.

Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects

C. McDougle, G. Pelton, L. Price, 1998, Neuropsychopharmacology.

A 10‐item smell identification scale related to risk for Alzheimer's disease

Yaakov Stern, Karen Marder, K. Marder, 2005, Annals of neurology.

Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance

Yaakov Stern, Christian G. Habeck, James Ralph Moeller, 2004, NeuroImage.

Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Richard L. Doty, Yaakov Stern, Gnanavalli Pradhaban, 2008, Biological Psychiatry.

Antidepressant treatment of melancholia in older adults.

H. Sackeim, D. Devanand, G. Pelton, 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study

H. Sackeim, G. Pelton, M. Tabert, 2008, International journal of geriatric psychiatry.

Combined treatment with memantine/es‐citalopram for older depressed patients with cognitive impairment: a pilot study

K. Marder, D. Devanand, G. Pelton, 2016, International journal of geriatric psychiatry.

Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients.

H. Sackeim, D. Devanand, G. Pelton, 2004, Journal of affective disorders.

Plasma Aβ and PET PIB binding are inversely related in mild cognitive impairment

R. Mayeux, Y. Stern, R. Parsey, 2011, Alzheimer's & Dementia.

PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment

Yaakov Stern, Christian G Habeck, Nikolaos Scarmeas, 2006, Neuropsychopharmacology.

Vascular depression: overrepresented among African Americans?

D. Devanand, G. Pelton, S. Roose, 2014, International journal of geriatric psychiatry.

Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.

J. Petrella, P. Doraiswamy, D. Devanand, 2018, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

R. Mayeux, Y. Stern, D. Devanand, 2005, Archives of neurology.

Sertraline treatment of elderly patients with depression and cognitive impairment

H. Sackeim, Y. Stern, G. Pelton, 2003, International journal of geriatric psychiatry.

Relapse risk after discontinuation of risperidone in Alzheimer's disease.

D. Devanand, G. Pelton, H. Andrews, 2012, The New England journal of medicine.

The Neurobiology of Tryptophan Depletion in Depression: Effects of Intravenous Tryptophan Infusion

C. McDougle, G. Pelton, L. Price, 1998, Biological Psychiatry.

Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.

G. Pelton, Seonjoo Lee, M. Husain, 2021, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

David M. Shade, J. Yesavage, L. Schneider, 2015, International Psychogeriatrics.

Effects of Antiglucocorticoid Treatment on 5-HT1A Function in Depressed Patients and Healthy Subjects

C. McDougle, G. Pelton, L. Price, 1997, Neuropsychopharmacology.

Change in cognitive functioning following acute antidepressant treatment in late-life depression.

D. Devanand, G. Pelton, J. Keilp, 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.

D. Devanand, G. Pelton, D. Devanand, 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.

David M. Shade, J. Yesavage, L. Schneider, 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).

B. Tycko, Y. Stern, D. Devanand, 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment.

J. Petrella, P. Doraiswamy, D. Devanand, 2021, Journal of affective disorders.

Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.

D. Devanand, G. Pelton, M. Husain, 2018, Contemporary clinical trials.

Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol.

K. Marder, G. Pelton, T. Cooper, 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.

David M. Shade, J. Yesavage, L. Schneider, 2016, The American journal of psychiatry.

Citalopram for agitation in Alzheimer’s disease: Design and methods

J. Yesavage, L. Schneider, C. Lyketsos, 2012, Alzheimer's & Dementia.

EffectofCitalopramonAgitationinAlzheimerDisease The CitAD Randomized Clinical Trial

David M. Shade, J. Yesavage, L. Schneider, 2014 .

Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis.

K. Marder, Y. Stern, G. Pelton, 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Change in Cognitive Functioning After Acute Antidepressant Treatment in Late-Life Depression

D. Devanand, G. Pelton, J. Keilp, 2009 .

Predictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment

Y. Stern, M. Sano, G. Pelton, 2010, Dementia and Geriatric Cognitive Disorders.

The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease

K. Marder, Y. Stern, G. Pelton, 2009, International journal of geriatric psychiatry.

The impact of mild cognitive impairment on functional abilities in the elderly

G. Pelton, S. Albert, D. Devanand, 2002, Current psychiatry reports.

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

Curtis L. Meinert, Bruce G. Pollock, Daniel Weintraub, 2014, Alzheimer's & Dementia.

The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.

D. Devanand, G. Pelton, H. Andrews, 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.

Y. Stern, D. Devanand, G. Pelton, 2020, Journal of Alzheimer's disease : JAD.

Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.

J. Petrella, P. Doraiswamy, G. Pelton, 2014, Contemporary clinical trials.

Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment

R. Mayeux, Y. Stern, R. Parsey, 2011, Neurology.